Clinical Trials · NCT03191396
Research Study Comparing a New Medicine Semaglutide to Liraglutide in People With Type 2 Diabetes
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 577
- Start date
- Jun 2017
- Locations
- 92 sites, 12 countries
- Primary endpoint
- Change in HbA1c